Chewy, Inc. research snapshot
CHWY AI stock analysis currently reads Chewy as a scaled online pet commerce platform with a valuable Autoship habit, 21.5 million active customers, improving gross margin, and positive free cash flow. The caution is that FY2026 revenue guidance was moderated to $13.40 billion to $13.55 billion while GAAP net margins remain low and the Modern Animal healthcare expansion adds integration risk. At the July 12, 2026 data cutoff, the last close was $20.88 and the verified market capitalization was about $8.55 billion. This CHWY AI stock analysis uses scenario ranges and dated source checks for information only, not a guaranteed stock price prediction or investment advice.
Current price
$20.88 at the July 10, 2026 close
Market cap
$8.55 billion verified market cap
AI score
64 / 100
Rating
Recurring pet commerce with improving cash flow, but consumer and execution risks remain
Trend status
High volatility, below the 50-day and 200-day moving averages after a guidance reset
Data cutoff (updated weekly)
July 12, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | Chewy combines a large online pet assortment, pharmacy and health offerings, customer service, fulfillment, private brands, and Autoship replenishment for recurring pet needs. | High |
| Moat | The practical moat is built from customer habit, Autoship data, fulfillment scale, selection, trust in prescriptions, and cross-selling across pet commerce and care. It is useful but not impregnable against Amazon, Walmart, Petco, and local veterinary networks. | Medium-high |
| Management | Sumit Singh has led the shift toward profitable growth, buybacks, health, and vet care. The CFO transition and the Modern Animal integration make capital allocation and operating discipline important 2026 tests. | Medium |
| Financial trend | FY2025 sales reached $12.60 billion, gross margin reached 29.8%, adjusted EBITDA grew to $719.2 million, and free cash flow reached $562.4 million. Q1 FY2026 sales grew 7.7% and adjusted EBITDA margin reached 7.5%. | High |
| Valuation | At $20.88, CHWY was near 34.8x trailing GAAP EPS, 14.6x trailing free cash flow per share, 0.67x sales, and 13.1x forward earnings in the available StockAnalysis snapshot. | Medium-high |
| Technical trend | The stock was below the 50-day average near $21.01 and well below the 200-day average near $28.55, although RSI near 54.9 showed a rebound from the 52-week low rather than an overbought condition. | Medium |
| Risk level | Key risks include softer discretionary pet spending, customer acquisition cost, freight and fulfillment costs, thin GAAP margins, competition, Modern Animal integration, dual-class voting control, and valuation compression. | Medium-high |
| AI confidence | Descriptive confidence is high because the main financial and operating facts are supported by SEC or company filings and a separate market-data source. Forward scenario confidence is medium. | High data confidence |
| Investment certainty | The business has recurring demand, but the equity needs continued margin expansion and customer growth to justify a higher multiple. This is a conditional research setup, not a buy signal. | Medium-low |
CHWY AI stock forecast
The CHWY AI stock forecast uses the July 10 close of $20.88, TTM GAAP EPS of $0.60, and a three-year scenario model. The audited outputs were about $44.3 for a bullish case, $22.8 for a base case, and $7.2 for a bearish case. The ranges below are deliberately wider than the point estimates and exclude dividends because Chewy currently pays none.
$38 to $46
More likely if active customers keep growing, Autoship remains above 80% of sales, gross margin expands, Chewy Health and Modern Animal add useful customer lifetime value, FY2026 revenue lands near the upper end of guidance, and investors support a premium multiple near 30x normalized earnings.
$20 to $25
More likely if sales grow near the FY2026 guidance range, active customers and Autoship grow at a slower but positive rate, adjusted EBITDA margin stays near the 6.6% to 6.8% target, and the market values improving cash flow around the low-20s earnings multiple.
$7 to $10
More likely if consumer pressure reduces premium and discretionary pet purchases, customer acquisition becomes more expensive, fulfillment costs rise, Modern Animal consumes cash without improving retention, or the market re-rates Chewy toward a low-teens earnings multiple.
CHWY AI technical analysis
CHWY AI technical analysis is mixed as of the July 12, 2026 cutoff. The last close at $20.88 was just below the 50-day moving average near $21.01 and far below the 200-day average near $28.55. RSI near 54.9 was neutral, while the 52-week range of $17.40 to $43.50 and beta of 1.44 show that price risk remains high.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $20.88 | StockAnalysis historical data recorded the July 10, 2026 close. All technical levels are snapshots, not permanent support or resistance. |
| Near support | $19.00 to $20.00 | Late-June and early-July trading repeatedly held this area after the post-earnings decline. A close below it would weaken the short-term rebound. |
| Deeper support | $17.40 to $18.00 | The $17.40 level was the available 52-week low and the nearby June 2026 washout zone. |
| Near resistance | $21.00 to $21.20 | The 50-day moving average was near $21.01 and the July 10 intraday high was $21.20. A sustained reclaim would improve the short-term trend. |
| Higher resistance | $24.50 to $25.50 | May 2026 trading clustered in this area before the sharp decline. It is a higher reference zone if the stock clears the 50-day average. |
| Moving averages | 50-day $21.01, 200-day $28.55 | StockAnalysis technical statistics snapshot reviewed July 11, 2026. |
| Momentum | RSI 54.89 | The reading is close to neutral and does not independently confirm either a strong trend or an oversold reversal. |
| Volume | 20-day average about 10.58 million shares | Use volume expansion to test a move through $21.20. The July 10 session traded about 5.94 million shares, below the 20-day average. |
| Volatility | Beta 1.44; 52-week range $17.40 to $43.50 | The large range and above-market beta make position sizing and gap risk important around earnings and guidance updates. |
| Invalidation | Sustained close below $17.40 | A decisive break below the 52-week low would invalidate the current rebound framework and require a fresh thesis review. |
CHWY AI trading strategy
The CHWY AI trading strategy below is a rules-based research framework, not personalized advice. It combines price confirmation with customer, margin, cash-flow, and healthcare integration checks.
Watch for CHWY to reclaim $21.00 to $21.20 and hold that area with volume above the 20-day average. A later move toward $24.50 to $25.50 would need improving revenue guidance and continued margin delivery.
A failed reclaim followed by a close below $19.00 should reduce confidence. A break below $17.40 invalidates the short-term rebound setup.
If CHWY revisits $19.00 to $20.00 while active customers, Autoship, gross margin, and free cash flow remain healthy, compare the price with updated earnings power before treating the level as support.
Do not average down solely because the stock is far below its 52-week high. A weakening customer trend or lower FY2026 guidance can make historical support unreliable.
Track Q2 sales against the $3.30 billion to $3.33 billion guide, FY2026 sales of $13.40 billion to $13.55 billion, adjusted EBITDA margin of 6.6% to 6.8%, active customers, Autoship sales, gross margin, free cash flow, buybacks, and Modern Animal integration.
Reduce confidence if growth depends on share-based compensation adjustments or cost cuts instead of customer retention, healthy gross profit, cash conversion, and durable operating leverage.
Investment research summary
Customers pay Chewy for convenient replenishment of food, supplies, prescriptions, and pet-health products. The core value is a trusted digital relationship that reduces the effort of managing recurring pet needs. Autoship turns part of that relationship into repeat demand, but the company still operates a physical inventory and fulfillment network.
The moat is practical rather than absolute. Chewy has 21.5 million active customers, about 190,000 product and service offerings, relationships with roughly 4,000 brands, Autoship behavior, pharmacy trust, fulfillment scale, and a strong service reputation. Amazon, Walmart, Petco, PetSmart, manufacturers, and local clinics can still compete for the same customer.
The thesis fails if customer acquisition costs rise faster than lifetime value, pet spending becomes more discretionary, freight and fulfillment costs pressure the roughly 30% gross margin, or Autoship growth hides weaker new-customer economics. Modern Animal can also consume management attention and capital before its strategic benefits are proven.
Sumit Singh has overseen the move toward profitable growth, higher gross margin, health services, and shareholder returns. Chewy returned about $200 million through executed share repurchases in Q1 FY2026 and appointed Chris Deppe as CFO in February 2026. The proxy also shows a dual-class structure in which BC Partners held 88.4% of total voting power, so governance alignment and control deserve monitoring.
Pet ownership, recurring consumables, prescription fulfillment, and digital convenience support a durable category. Chewy is extending into veterinary care through Chewy Vet Care and the Modern Animal acquisition, which was expected to add over $125 million of annualized revenue and expand the clinic footprint from 18 to 47 locations. The opportunity is large, but care delivery has different staffing, regulatory, and operating requirements from e-commerce.
At $20.88, CHWY looked expensive on trailing GAAP earnings at about 34.8x, but more moderate on trailing free cash flow at about 14.6x and sales at about 0.67x. The margin of safety depends on turning improving adjusted EBITDA and free cash flow into durable GAAP earnings without excessive dilution or acquisition spending.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| CHWY closing price | $20.88 | StockAnalysis historical prices | July 10, 2026 close |
| Market capitalization and shares | $8.55 billion; 409.42 million shares | StockAnalysis statistics | July 11, 2026 |
| FY2025 net sales | $12.60 billion | Chewy FY2025 results and SEC 10-K | March 25, 2026 |
| FY2025 net income and free cash flow | $222.8 million net income; $562.4 million free cash flow | SEC FY2025 Form 10-K | March 25, 2026 filing |
| Q1 FY2026 net sales and gross margin | $3.357 billion; 30.1% gross margin | Chewy Q1 FY2026 results | June 10, 2026 |
| Q1 FY2026 active customers and Autoship sales | 21.497 million active customers; 84.4% of sales from Autoship customers | Chewy Q1 FY2026 results | June 10, 2026 |
| Q1 FY2026 cash and marketable securities | $520.1 million combined | Chewy Q1 FY2026 balance sheet | May 3, 2026 balance-sheet date |
| FY2026 revenue and margin guidance | $13.40 billion to $13.55 billion sales; 6.6% to 6.8% adjusted EBITDA margin | Chewy Q1 FY2026 earnings presentation | June 10, 2026 |
| Technical snapshot | 50-day $21.01; 200-day $28.55; RSI 54.89; beta 1.44 | StockAnalysis statistics | July 11, 2026 |
| Modern Animal acquisition context | Over $125 million annualized run-rate revenue; clinic footprint from 18 to 47 | Chewy acquisition announcement | April 8, 2026 announcement |
| Voting control | BC Partners held 88.4% of total voting power in the 2026 proxy table | Chewy 2026 proxy statement | May 13, 2026 ownership date |
This page is an information tool, not investment advice, a recommendation, or a promise of returns. Forecast ranges are scenarios based on available data and assumptions that may be wrong. Market prices, technical levels, financial results, and company guidance can change after the July 12, 2026 data cutoff. Verify current filings and market data before making any decision.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
